Effect of quinapril initiated during progressive remodeling in asymptomatic patients with healed myocardial infarction

American Journal of Cardiology

Volumn 86, Issue 2, 2000, Pages 139-144

  Gaudron, Peter ^a   Kugler, Lngrid ^a   Hu, Kai ^a   Fraccarollo, Daniela ^a   Bauer, Wolfgang ^a   Eilles, Christoph ^b   Ertl, Georg ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; QUINAPRIL;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXERCISE; FEMALE; HEART CATHETERIZATION; HEART DILATATION; HEART INDEX; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN TENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; GATED BLOOD-POOL IMAGING; HEMODYNAMIC PROCESSES; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; TETRAHYDROISOQUINOLINES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0034045723     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00849-3     Document Type: Article

References (22)

1. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial MI. Experimental observations and clinical implications. Circulation. 81:1990;1161-1172.
2. McKay R.G., Pfeffer M.A., Pasternak R.C., Markis J., Come P.C., Nakao S., Alderman J.D., Ferguson J.J., Safian R.D., Grossman W. LV remodeling after myocardial MI a corollary to infarct expansion . Circulation. 74:1986;693-702.
3. Gaudron P., Eilles C., Ertl G., Kochsiek K. Compensatory and non-compensatory LV dilatation after myocardial MI time course, hemodynamic consequences at rest and exercise . Am Heart J. 123:1992;377-385.
4. Gaudron P., Eilles C., Kugler L., Ertl G. Progressive LV dysfunction and remodeling after myocardial MI potential mechanisms and early predictors . Circulation. 87:1993;755-763.
5. White H.D., Norris R.M., Brown M.A., Brandt P.W.T., Whitlock R.M.L., Wild C.J. LV end-systolic volume as the major determinant of survival after recovery from myocardial MI. Circulation. 76:1987;44-51.
6. Pfeffer M.A., Lamas G.A., Vaughan D.E., Parisi A.F., Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial MI. N Engl J Med. 319:1988;80-86.
7. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geitman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM. Effect of captopril on mortality and morbidity in patients with LV dysfunction after myocardial MI. N Engl J Med 1992;327:669-677.
8. St. John Sutton M., Pfeffer M.A., Plappert T., Rouleau J.L., Moye L.A., Dagenais G.R., Lamas G.A., Klein M., Sussex B., Goldman S., Menapace F.J., Parker J.O., Lewis S., Sestier F., Gordon D.F., McEwan P., Bernstein V., Braunwald E. Quantitative 2-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial MI the protective effects of captopril . Circulation. 89:1994;68-75.
9. Sharpe N., Smith H., Murphy J., Hannan S. Treatment of patients with symptomless LV dysfunction after myocardial MI. Lancet. 1:1988;255-259.
10. Effects of enalapril on mortality in severe congestive congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) . N Engl J Med. 316:1987;1429-1435.
11. Effect of enalapril on survival in patients with reduced LV ejection fraction and congestive heart failure. N Engl J Med. 325:1991;293-302.
12. Cohn J.N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W.B., Loeb H., Wong M., Bhat G., Goldman S., Fletcher R.D., Doherty J., Hughes C.V., Carson P., Cintron G., Shabetai R., Haakenson C. A comparison of enalapril with hydralazine isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310.
13. Greenberg B., Quinones M.A., Koilpillai C., Limacher M., Shindler D., Benedict C., Shelton B. Effects of long-term enalapril therapy on cardiac structure and function in patients with LV dysfunction. Results of the SOLVD echocardiography substudy. Circulation. 91:1995;2573-2581.
14. Feild B.J., Russell R.O., Dowilng J.T., Rackley C.E. Regional LV performance in the year following myocardial MI. Circulation. 46:1972;679-689.
15. Fletcher G.F., Balaly G., Hartley L.H., Froelicher V.F., Haskell W.L., Pollock M.L. Exercise standards a statement for healthcare professionals from the American Heart Association . Circulation. 91:1994;580-615.
16. LeJemtel T.H., Liang C.S., Stewart D.K., Kirlin P.C., McIntyre K.M., Robertson T.H., Moore A., Cahill L., Galvao M., Wellington K.L., Garces C., Held P. Reduced peak aerobic capacity in asymptomatic LV systolic dysfunction a substudy of the studies of LV dysfunction (SOLVD) . Circulation. 90:1994;2757-2760.
17. Wallenstein S., Zucker C.L., Fleiss J.L. Some statistical methods useful in circulation research. Circ Res. 47:1980;1-9.
18. Gaudron P., Eilles C., Ertl G., Kochsiek K. Early remodelling of the left ventricle in patients with myocardial MI. Eur Heart J. 11:1990;139-146.
19. Konstam M.A., Kronenberg M.W., Rousseau M.F., Udelson J.E., Melin J., Stewart D., Dolan N., Edens T.R., Ahn S., Kinan D., Howe D.M., Kilcoyne L., Metherall J., Benedict C., Yusuf S., Pouleur H. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of LV dilatation in patients with asymptomatic systolic dysfunction. Circulation. 88:1993;2277-2283.
20. Konstam M.A., Rousseau M.F., Kronenberg M.W., Udelson J.E., Melin J., Stewart D., Dolan N., Edens T.R., Ahn S., Kinan D., Howe D.M., Kilcoyne L., Metherall J., Benedict C., Yusuf S., Pouleur H. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of LV dysfunction in patients with heart failure. Circulation. 86:1992;431-438.
21. Pouleur H., Rousseau M.F., Van Eyil C., Stoleru L., Hayashida W., Udelson J.A., Dolan N., Kinan D., Gallagher P., Ahn S., Benedict C.R., Yusuf S., Konstam M. Effects of long-term enalapril therapy on LV diastolic properties in patients with depressed ejection fraction. Circulation. 88:1993;481-491.
22. Kingma J.H., Van Gilst W.H., Peels C.H., Dambrink J.H.E., Verheugt F.W.A., Wielenga R.P. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial MI - results from the Captopril and Thrombolysis Study (CATS). Eur Heart J. 15:1994;898-907.